Helmut Zarbl Ph.D.Professor, NIEHS Center Director Rutgers UniversityEOHSI – Toxicology
Dr. Zarbl serves as the Director of the NIEHS sponsored Center for Environmental Exposures and Disease. He is also the Associate Director For Public Health Sciences at the Cancer Institute of New Jersey. He serves on numerous national research review and advisory panels, and editorial panels.. Dr. Zarbl is known for his work in areas of toxicogenomics, and mechanisms of and genetic susceptibility to chemical carcinogenesis, mechanisms of mutagenesis and toxicity, and technology development. These research efforts have to date resulted in over 70 scientific papers and book chapters.
Research has focused largely on toxicogenomics and functional genomics, carcinogenesis, molecular and cellular biology, and toxicology. Specifically this has included work understand to molecular mechanisms of chemical carcinogenesis and the genetic basis for differential susceptibility to mammary carcinogenesis using animal and in vitro model systems, and then translating the findings to human breast cancer.
Studies in the rat model have included analysis of oncogene activation, mechanisms of signal transduction, and genetic linkage analysis to identify mammary tumor suppressor genes. He has also used toxicogenomics to dissect mechanisms of mechanism carcinogenesis, tumor progression and chemoprevention. His studies in the area of toxicogenomics include the development and application of standards for DNA microarray experiments, and phenotypic anchoring of response of human cells, model organisms (yeast) and target organs (rodents) to toxicants, providing insights into dose and temporal responses, as well as mechanisms of action. He is also actively involved in technology development for functional genomics and biomarker screening.
- Sunil, VR, Vayas, KN, Fang, M, Zarbl, H, Massa, C, Gow, AJ, Cervelli, JA, Kipen, H, Laumbach, RJ, Lioy, PJ et al.. World Trade Center (WTC) dust exposure in mice is associated with inflammation, oxidative stress and epigenetic changes in the lung. Exp. Mol. Pathol. 2017;102 (1):50-58. doi: 10.1016/j.yexmp.2016.12.005. PubMed PMID:27986442
- Klaene, JJ, Flarakos, C, Glick, J, Barret, JT, Zarbl, H, Vouros, P. Tracking matrix effects in the analysis of DNA adducts of polycyclic aromatic hydrocarbons. J Chromatogr A. 2016;1439 :112-23. doi: 10.1016/j.chroma.2015.10.057. PubMed PMID:26607319 PubMed Central PMC4789121
- Fang, M, Guo, WR, Park, Y, Kang, HG, Zarbl, H. Enhancement of NAD⁺-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells. Oncotarget. 2015;6 (40):42879-91. doi: 10.18632/oncotarget.6002. PubMed PMID:26544624 PubMed Central PMC4767478
- Fang, MZ, Ohman-Strickland, P, Kelly-McNeil, K, Kipen, H, Crabtree, BF, Lew, JP, Zarbl, H. Sleep interruption associated with house staff work schedules alters circadian gene expression. Sleep Med. 2015;16 (11):1388-94. doi: 10.1016/j.sleep.2015.06.011. PubMed PMID:26498241 PubMed Central PMC4621493
- Green, AL, Hossain, MM, Tee, SC, Zarbl, H, Guo, GL, Richardson, JR. Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells. Neurochem. Res. 2015;40 (7):1372-8. doi: 10.1007/s11064-015-1601-6. PubMed PMID:25963949 PubMed Central PMC4745645
- Mukherjee, D, Royce, SG, Alexander, JA, Buckley, B, Isukapalli, SS, Bandera, EV, Zarbl, H, Georgopoulos, PG. Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study. PLoS ONE. 2014;9 (12):e113632. doi: 10.1371/journal.pone.0113632. PubMed PMID:25474635 PubMed Central PMC4256163
- Ren, X, Graham, JC, Jing, L, Mikheev, AM, Gao, Y, Lew, JP, Xie, H, Kim, AS, Shang, X, Friedman, C et al.. Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene. PLoS ONE. 2013;8 (9):e70930. doi: 10.1371/journal.pone.0070930. PubMed PMID:24023717 PubMed Central PMC3759375